(TS) Tenaris - Overview
Exchange: NYSE •
Country: Luxembourg •
Currency: USD •
Type: Common Stock •
ISIN: US88031M1099
Stock: Steel Pipes, Industrial Tubes, Energy Services, Connections
Total Rating 60
Risk 85
Buy Signal 1.10
| Risk 5d forecast | |
|---|---|
| Volatility | 29.2% |
| Relative Tail Risk | -7.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.25 |
| Alpha | 30.44 |
| Character TTM | |
|---|---|
| Beta | 0.982 |
| Beta Downside | 1.476 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.81% |
| CAGR/Max DD | 0.98 |
EPS (Earnings per Share)
Revenue
Description: TS Tenaris March 05, 2026
Tenaris S.A. (TS) manufactures and supplies steel pipe products and related services for the energy industry and other industrial applications globally.
The companys product lines include steel casings and tubing for oil and gas wells, line pipes for hydrocarbon transport, and mechanical/structural pipes for high-pressure gas and liquid transfer. This business model focuses on providing essential infrastructure materials to the upstream and midstream energy sectors.
Tenaris also offers specialized products like cold-drawn pipes for various industrial applications, premium joints under proprietary brands, coiled tubing, and sucker rods. They provide pipe coating services and automotive components, diversifying their offerings beyond core energy infrastructure. The company also engages in raw material sales, intellectual property management, and financial operations.
For more detailed analysis of Tenariss financial performance and market position, ValueRay offers comprehensive reports.
Headlines to watch out for
- Oil and gas drilling activity drives demand for steel pipe products
- Steel and energy input costs impact production margins
- Global energy transition policies influence long-term demand
- Geopolitical stability affects oil and gas exploration investment
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.93b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.49 > 1.0 |
| NWC/Revenue: 56.20% < 20% (prev 52.70%; Δ 3.51% < -1%) |
| CFO/TA 0.13 > 3% & CFO 2.65b > Net Income 1.93b |
| Net Debt (-123.7m) to EBITDA (3.18b): -0.04 < 3 |
| Current Ratio: 3.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (519.8m) vs 12m ago -52.67% < -2% |
| Gross Margin: 32.06% > 18% (prev 0.35%; Δ 3.17k% > 0.5%) |
| Asset Turnover: 59.07% > 50% (prev 61.24%; Δ -2.17% > 0%) |
| Interest Coverage Ratio: 53.57 > 6 (EBITDA TTM 3.18b / Interest Expense TTM 47.0m) |
Altman Z'' 10.00
| A: 0.34 (Total Current Assets 9.07b - Total Current Liabilities 2.35b) / Total Assets 20.07b |
| B: 0.88 (Retained Earnings 17.73b / Total Assets 20.07b) |
| C: 0.12 (EBIT TTM 2.52b / Avg Total Assets 20.26b) |
| D: 5.12 (Book Value of Equity 16.60b / Total Liabilities 3.24b) |
| Altman-Z'' Score: 11.29 = AAA |
Beneish M -3.00
| DSRI: 1.05 (Receivables 1.96b/1.96b, Revenue 11.97b/12.52b) |
| GMI: 1.09 (GM 32.06% / 35.04%) |
| AQI: 0.96 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 0.96 (Revenue 11.97b / 12.52b) |
| TATA: -0.04 (NI 1.93b - CFO 2.65b) / TA 20.07b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of TS shares?
As of March 17, 2026, the stock is trading at USD 53.84 with a total of 1,538,346 shares traded.
Over the past week, the price has changed by +1.16%, over one month by +9.03%, over three months by +36.34% and over the past year by +45.68%.
Over the past week, the price has changed by +1.16%, over one month by +9.03%, over three months by +36.34% and over the past year by +45.68%.
Is TS a buy, sell or hold?
Tenaris has received a consensus analysts rating of 3.82.
Therefore, it is recommended to buy TS.
- StrongBuy: 4
- Buy: 4
- Hold: 1
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.5 | -6.2% |
| Analysts Target Price | 50.5 | -6.2% |
TS Fundamental Data Overview March 14, 2026
P/E Trailing = 14.6202
P/E Forward = 17.9856
P/S = 2.2546
P/B = 1.655
P/EG = 3.1501
Revenue TTM = 11.97b USD
EBIT TTM = 2.52b USD
EBITDA TTM = 3.18b USD
Long Term Debt = 2.25m USD (from longTermDebt, two quarters ago)
Short Term Debt = 353.7m USD (from shortTermDebt, last quarter)
Debt = 449.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -123.7m USD (from netDebt column, last quarter)
Enterprise Value = 24.58b USD (27.01b + Debt 449.0m - CCE 2.88b)
Interest Coverage Ratio = 53.57 (Ebit TTM 2.52b / Interest Expense TTM 47.0m)
EV/FCF = 12.19x (Enterprise Value 24.58b / FCF TTM 2.02b)
FCF Yield = 8.20% (FCF TTM 2.02b / Enterprise Value 24.58b)
FCF Margin = 16.85% (FCF TTM 2.02b / Revenue TTM 11.97b)
Net Margin = 16.13% (Net Income TTM 1.93b / Revenue TTM 11.97b)
Gross Margin = 32.06% ((Revenue TTM 11.97b - Cost of Revenue TTM 8.13b) / Revenue TTM)
Gross Margin QoQ = 24.56% (prev 34.65%)
Tobins Q-Ratio = 1.22 (Enterprise Value 24.58b / Total Assets 20.07b)
Interest Expense / Debt = 3.53% (Interest Expense 15.8m / Debt 449.0m)
Taxrate = 23.58% (142.2m / 603.3m)
NOPAT = 1.92b (EBIT 2.52b * (1 - 23.58%))
Current Ratio = 3.87 (Total Current Assets 9.07b / Total Current Liabilities 2.35b)
Debt / Equity = 0.03 (Debt 449.0m / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.04 (Net Debt -123.7m / EBITDA 3.18b)
Debt / FCF = -0.06 (Net Debt -123.7m / FCF TTM 2.02b)
Total Stockholder Equity = 16.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.53% (Net Income 1.93b / Total Assets 20.07b)
RoE = 11.46% (Net Income TTM 1.93b / Total Stockholder Equity 16.85b)
RoCE = 14.94% (EBIT 2.52b / Capital Employed (Equity 16.85b + L.T.Debt 2.25m))
RoIC = 11.15% (NOPAT 1.92b / Invested Capital 17.26b)
WACC = 9.42% (E(27.01b)/V(27.46b) * Re(9.53%) + D(449.0m)/V(27.46b) * Rd(3.53%) * (1-Tc(0.24)))
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.98%
[DCF] Terminal Value 70.16% ; FCFF base≈2.07b ; Y1≈1.77b ; Y5≈1.37b
[DCF] Fair Price = 39.31 (EV 19.72b - Net Debt -123.7m = Equity 19.85b / Shares 504.8m; r=9.42% [WACC]; 5y FCF grow -17.51% → 2.90% )
EPS Correlation: -35.73 | EPS CAGR: 0.62% | SUE: 0.23 | # QB: 0
Revenue Correlation: -6.55 | Revenue CAGR: 6.48% | SUE: 0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.85 | Chg7d=+0.022 | Chg30d=+0.022 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=3.46 | Chg7d=+0.020 | Chg30d=+0.020 | Revisions Net=+3 | Growth EPS=-5.4% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=3.66 | Chg7d=+0.034 | Chg30d=+0.034 | Revisions Net=-1 | Growth EPS=+5.7% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 9.5% - Earnings Yield 6.8%)
[Growth] Growth Spread = -7.3% (Analyst -4.6% - Implied 2.7%)
P/E Forward = 17.9856
P/S = 2.2546
P/B = 1.655
P/EG = 3.1501
Revenue TTM = 11.97b USD
EBIT TTM = 2.52b USD
EBITDA TTM = 3.18b USD
Long Term Debt = 2.25m USD (from longTermDebt, two quarters ago)
Short Term Debt = 353.7m USD (from shortTermDebt, last quarter)
Debt = 449.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -123.7m USD (from netDebt column, last quarter)
Enterprise Value = 24.58b USD (27.01b + Debt 449.0m - CCE 2.88b)
Interest Coverage Ratio = 53.57 (Ebit TTM 2.52b / Interest Expense TTM 47.0m)
EV/FCF = 12.19x (Enterprise Value 24.58b / FCF TTM 2.02b)
FCF Yield = 8.20% (FCF TTM 2.02b / Enterprise Value 24.58b)
FCF Margin = 16.85% (FCF TTM 2.02b / Revenue TTM 11.97b)
Net Margin = 16.13% (Net Income TTM 1.93b / Revenue TTM 11.97b)
Gross Margin = 32.06% ((Revenue TTM 11.97b - Cost of Revenue TTM 8.13b) / Revenue TTM)
Gross Margin QoQ = 24.56% (prev 34.65%)
Tobins Q-Ratio = 1.22 (Enterprise Value 24.58b / Total Assets 20.07b)
Interest Expense / Debt = 3.53% (Interest Expense 15.8m / Debt 449.0m)
Taxrate = 23.58% (142.2m / 603.3m)
NOPAT = 1.92b (EBIT 2.52b * (1 - 23.58%))
Current Ratio = 3.87 (Total Current Assets 9.07b / Total Current Liabilities 2.35b)
Debt / Equity = 0.03 (Debt 449.0m / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.04 (Net Debt -123.7m / EBITDA 3.18b)
Debt / FCF = -0.06 (Net Debt -123.7m / FCF TTM 2.02b)
Total Stockholder Equity = 16.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.53% (Net Income 1.93b / Total Assets 20.07b)
RoE = 11.46% (Net Income TTM 1.93b / Total Stockholder Equity 16.85b)
RoCE = 14.94% (EBIT 2.52b / Capital Employed (Equity 16.85b + L.T.Debt 2.25m))
RoIC = 11.15% (NOPAT 1.92b / Invested Capital 17.26b)
WACC = 9.42% (E(27.01b)/V(27.46b) * Re(9.53%) + D(449.0m)/V(27.46b) * Rd(3.53%) * (1-Tc(0.24)))
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.98%
[DCF] Terminal Value 70.16% ; FCFF base≈2.07b ; Y1≈1.77b ; Y5≈1.37b
[DCF] Fair Price = 39.31 (EV 19.72b - Net Debt -123.7m = Equity 19.85b / Shares 504.8m; r=9.42% [WACC]; 5y FCF grow -17.51% → 2.90% )
EPS Correlation: -35.73 | EPS CAGR: 0.62% | SUE: 0.23 | # QB: 0
Revenue Correlation: -6.55 | Revenue CAGR: 6.48% | SUE: 0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.85 | Chg7d=+0.022 | Chg30d=+0.022 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=3.46 | Chg7d=+0.020 | Chg30d=+0.020 | Revisions Net=+3 | Growth EPS=-5.4% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=3.66 | Chg7d=+0.034 | Chg30d=+0.034 | Revisions Net=-1 | Growth EPS=+5.7% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 9.5% - Earnings Yield 6.8%)
[Growth] Growth Spread = -7.3% (Analyst -4.6% - Implied 2.7%)